Track BIOLASE, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BIOLASE, Inc. BIOL · Stock Open BIOLASE, Inc. in new tab

0.0200 USD
P/E
0.00
EPS
16.18
ROE
-736.26
Beta
0.68
Target Price
1.20 USD
Loading chart...
Key Metrics
P/E0.00
EPS16.18
Book Value-0.13
% Insiders0.298%
Growth
Revenue Growth-0.19%
Estimates
Forward P/E-1.29
Forward EPS-0.10
Target Mean Price1.20

DCF valuation

Model fair value for BIOLASE, Inc. (BIOL)
Result
Sign in to run the valuation for BIOL.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 1.20 USD (low 0.40, high 2.00)
Low 0.40
Mean 1.20
High 2.00
Price 0.0200
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

BIOLASE, Inc. Logo BIOLASE, Inc. Analysis (BIOL)

United States Health Care Official Website Stock

Is BIOLASE, Inc. a good investment? BIOLASE, Inc. (BIOL) is currently trading at 0.0200 USD. Market analysts have a consensus price target of 1.20 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that BIOLASE, Inc. is undervalued compared to historical market norms.

Investor FAQ

Does BIOLASE, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is BIOLASE, Inc.?

BIOLASE, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. On October 1, 2024, BIOLASE, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Exchange Ticker
NCM (Australia) BIOL
US BIOLQ
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2005
0.03 USD
July 12, 2005 0.0100
May 9, 2005 0.0100
Feb. 24, 2005 0.0100
▸2004
0.03 USD
Dec. 29, 2004 0.0100
Oct. 27, 2004 0.0100
Aug. 30, 2004 0.0100
Stock Splits
Split Date Split Ratio to 1
Feb. 15, 1994 1:4
March 11, 2011 1.01
June 8, 2011 1.01
Aug. 25, 2011 1.01
Nov. 22, 2011 1.01
March 13, 2012 1.01
June 6, 2012 1.01
Sept. 12, 2012 1.01
Dec. 12, 2012 1.01
March 13, 2013 1.01
June 12, 2013 1.01
Aug. 28, 2013 1.01
Dec. 12, 2013 1.01
March 12, 2014 1.01
May 11, 2018 1:5
April 29, 2022 1:25
July 28, 2023 1:100
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion